A Trial of Strontium +/- Cisplatin for the Palliation of Bone Pain Secondary to Hormone Refractory Prostate Cancer

NCT00156884 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

58

Enrollment

OTHER

Sponsor class

Conditions

Hormone Refractory Prostate Cancer
Bone Metastases

Interventions

DRUG: strontium-89
DRUG: cisplatin

Sponsor

Alberta Health services

Collaborators

[object Object]
[object Object]